Pages that link to "Q46096212"
Jump to navigation
Jump to search
The following pages link to Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease (Q46096212):
Displaying 9 items.
- New bisphosphonates in the treatment of bone diseases (Q33785411) (← links)
- Treatment of patients with Paget's disease of bone (Q33793210) (← links)
- Paget's disease of bone: diagnosis and treatment update (Q34108849) (← links)
- The effect of dosing regimen on the pharmacokinetics of risedronate (Q36053896) (← links)
- Effect of renal function on risedronate pharmacokinetics after a single oral dose (Q36055114) (← links)
- Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management (Q36059397) (← links)
- New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis (Q36106531) (← links)
- Radiological features of Paget disease of bone associated with VCP myopathy (Q46105751) (← links)
- Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline. (Q53033362) (← links)